These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 2952898

  • 1. Differential effects of serotonin (5-HT1A and 5-HT2) agonists and antagonists on renin and corticosterone secretion.
    Lorens SA, Van de Kar LD.
    Neuroendocrinology; 1987 Apr; 45(4):305-10. PubMed ID: 2952898
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists.
    Bagdy G, Sved AF, Murphy DL, Szemeredi K.
    Eur J Pharmacol; 1992 Jan 21; 210(3):285-9. PubMed ID: 1535317
    [Abstract] [Full Text] [Related]

  • 5. Neuroendocrine evidence for denervation supersensitivity of serotonin receptors: effects of the 5-HT agonist RU 24969 on corticotropin, corticosterone, prolactin and renin secretion.
    Van de Kar LD, Carnes M, Maslowski RJ, Bonadonna AM, Rittenhouse PA, Kunimoto K, Piechowski RA, Bethea CL.
    J Pharmacol Exp Ther; 1989 Nov 21; 251(2):428-34. PubMed ID: 2553918
    [Abstract] [Full Text] [Related]

  • 6. Stimulation of corticosterone and beta-endorphin secretion in the rat by selective 5-HT receptor subtype activation.
    Koenig JI, Gudelsky GA, Meltzer HY.
    Eur J Pharmacol; 1987 May 07; 137(1):1-8. PubMed ID: 2956114
    [Abstract] [Full Text] [Related]

  • 7. Stimulation of corticosterone secretion by the selective 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the rat.
    Przegaliński E, Budziszewska B, Warchoł-Kania A, Błaszczyńska E.
    Pharmacol Biochem Behav; 1989 Jun 07; 33(2):329-34. PubMed ID: 2530590
    [Abstract] [Full Text] [Related]

  • 8. Serotonin receptor subtypes involved in the elevation of serum corticosterone concentration in rats by direct- and indirect-acting serotonin agonists.
    Fuller RW, Snoddy HD.
    Neuroendocrinology; 1990 Aug 07; 52(2):206-11. PubMed ID: 2148812
    [Abstract] [Full Text] [Related]

  • 9. Central 5-HT1A receptors inhibit adrenocortical secretion.
    Welch JE, Farrar GE, Dunn AJ, Saphier D.
    Neuroendocrinology; 1993 Aug 07; 57(2):272-81. PubMed ID: 8510803
    [Abstract] [Full Text] [Related]

  • 10. Attenuation of 5-HT1A and 5-HT2 but not 5-HT1C receptor mediated behaviour in rats following chronic treatment with 5-HT receptor agonists, antagonists or anti-depressants.
    Berendsen HH, Broekkamp CL.
    Psychopharmacology (Berl); 1991 Aug 07; 105(2):219-24. PubMed ID: 1839064
    [Abstract] [Full Text] [Related]

  • 11. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
    Millan MJ, Rivet JM, Canton H, Lejeune F, Bervoets K, Brocco M, Gobert A, Lefebvre de Ladonchamps B, Le Marouille-Girardon S, Verriele L.
    J Pharmacol Exp Ther; 1992 Aug 07; 262(2):451-63. PubMed ID: 1323650
    [Abstract] [Full Text] [Related]

  • 12. Selective cross-tolerance to 5-HT1A and 5-HT2 receptor-mediated temperature and corticosterone responses.
    Nash JF, Meltzer HY, Gudelsky GA.
    Pharmacol Biochem Behav; 1989 Aug 07; 33(4):781-5. PubMed ID: 2533356
    [Abstract] [Full Text] [Related]

  • 13. Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Evidence for opposing roles of 5-HT2 and 5-HT1A receptors.
    Gudelsky GA, Koenig JI, Meltzer HY.
    Neuropharmacology; 1986 Dec 07; 25(12):1307-13. PubMed ID: 2951611
    [Abstract] [Full Text] [Related]

  • 14. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
    Dumuis A, Sebben M, Bockaert J.
    Mol Pharmacol; 1988 Feb 07; 33(2):178-86. PubMed ID: 2828913
    [Abstract] [Full Text] [Related]

  • 15. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
    Schechter LE, Bolaños FJ, Gozlan H, Lanfumey L, Haj-Dahmane S, Laporte AM, Fattaccini CM, Hamon M.
    J Pharmacol Exp Ther; 1990 Dec 07; 255(3):1335-47. PubMed ID: 1702155
    [Abstract] [Full Text] [Related]

  • 16. Repeated cocaine exposure inhibits the adrenocorticotropic hormone response to the serotonin releaser d-fenfluramine and the 5-HT1A agonist, 8-OH-DPAT.
    Levy AD, Li Q, Van de Kar LD.
    Neuropharmacology; 1994 Dec 07; 33(3-4):335-42. PubMed ID: 7984271
    [Abstract] [Full Text] [Related]

  • 17. Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice.
    Berendsen HH, Broekkamp CL.
    Br J Pharmacol; 1990 Nov 07; 101(3):667-73. PubMed ID: 2150180
    [Abstract] [Full Text] [Related]

  • 18. Effect of chronic treatment with 5-HT1 agonist (8-OH-DPAT and RU 24969) and antagonist (isapirone) drugs on the behavioural responses of mice to 5-HT1 and 5-HT2 agonists.
    De Souza RJ, Goodwin GM, Green AR, Heal DJ.
    Br J Pharmacol; 1986 Oct 07; 89(2):377-84. PubMed ID: 2946344
    [Abstract] [Full Text] [Related]

  • 19. Are 5-HT1A autoreceptors involved in the inhibitory effect of ipsapirone on cold-elicited thyrotropin secretion?
    Broqua P, Laude D, Bluet-Pajot MT, Schmidt B, Baudrie V, Chaouloff F.
    Neuroendocrinology; 1993 Apr 07; 57(4):640-7. PubMed ID: 7690117
    [Abstract] [Full Text] [Related]

  • 20. Repeated treatment with the 5-HT1A receptor agonist, ipsapirone, does not affect 8-OH-DPAT- and stress-induced increases in plasma adrenaline levels in the rat.
    Baudrie V, Chaouloff F.
    Eur J Pharmacol; 1991 Jun 06; 198(2-3):129-35. PubMed ID: 1830845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.